تطورات الدراسات الكيميائية للحصول علي عصارة فستقا البنفسج وتقديم المتطلبات العلمية.

  • role: First author第一作者
  • Affiliation:

    School of Pharmacy,Henan University of Chinese Medicine,Zhengzhou 450046,China

    Henan Key Laboratory of Traditional Cinese Medicine Resources and Chemistry,Zhengzhou 450046,China

  • Email:xlpxlp@aliyun.com
  • Introduction:E-mail xlpxlp@aliyun.com
PEI Lixin12,  
  • Affiliation:

    School of Pharmacy,Henan University of Chinese Medicine,Zhengzhou 450046,China

CHEN Lin1,  
  • Affiliation:

    School of Pharmacy,Henan University of Chinese Medicine,Zhengzhou 450046,China

LI Nuo1,  
  • Affiliation:

    School of Pharmacy,Henan University of Chinese Medicine,Zhengzhou 450046,China

ZHAO Mengyao1,  
  • Affiliation:

    School of Pharmacy,Henan University of Chinese Medicine,Zhengzhou 450046,China

YANG Haoyuan1,  
  • Affiliation:

    Chongqing Institute of Medicinal Plant Cultivation,Chongqing 408435,China

YANG Xiaoyu3,  
  • role: Corresponding author通信作者
  • Affiliation:

    School of Pharmacy,Henan University of Chinese Medicine,Zhengzhou 450046,China

    Henan Key Laboratory of Traditional Cinese Medicine Resources and Chemistry,Zhengzhou 450046,China

    Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao,Zhengzhou 450046,China

  • Email:584810680@qq.com
  • Introduction:E-mail584810680@qq.com
JI Baoyu124*

ملخص

الخريطة الكيميائية لعصارة فستقا البنفسج وتقدم متطلبات استبدال المعالجة.

مفهوم

عصارة فستقا البنفسج; الخريطة الكيميائية; المتطلبات العلمية; الإستخدام السريراني

References

  1. 1.
    Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China:Volume 1[M].Beijing:The Medicine Science and Technology Press of China,2020.
  2. 2.
    XU Y Q,Ll R Q,ZHANG H Y,et al.Distribution of Epimedium sagittatum and its research progress on quality characteristics[J].Chin Tradit Herbal Drugs,2020,51(23):6119-6132.
  3. 3.
    Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China:Volume 1[M].Beijing:The Medicine Science and Technology Press of China,2010:306.
  4. 4.
    Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China:Volume 1[M].Beijing:The Medicine Science and Technology Press of China,2015:327.
  5. 5.
    ZHAO Y K,LLU Y Y,SHL W,et al.Clinical characteristics and potential risk factors analysisof liver injury related to Epimedii Folium preparation[J].Chin J Exp Tradit Med Form,2024,30(6):205-210.
  6. 6.
    ZHANG Z J ,YAO J P,GUO Z Y,et al.Advances in study of icarrin for anti-aging and anti-depression:A review[J].Chin J Expe Tradit Med Form,2022,28(16):276-282.
  7. 7.
    LlU Y M,XU T,ZHANG H Q,et al.Material basis and mechanism of Epimedii Folium against osteoporosis based on spectrum-effect relationship and network pharmacology[J].Chin J Exp Tradit Med Form,2021,27(16):177-184.
  8. 8.
    LI L,AN Y J,QIAO C L,et al.Ultrasound-microwave-assisted extraction of alkaloids from Epimedium brevicornum and their inhibitory effect on HeLa cells[J].Chin Bull Bota,2018,53(3):341-352.
  9. 9.
    LU J,NlU X J,DUAN X Y.Optimization of extraction process for Epimedium polysaccharide by uniform design method[J].Mod Chin Med,2019,21(1):95-98.
  10. 10.
    ZHANG R T,WU H N ,YU G H,et al.Effective components and signaling pathways of Epimedium brevicornum based on network pharmacology[J].China J Chin Mater Med,2018,43(23):4709-4717.
  11. 11.
    KE Z P ,ZHANG X Z ,CAO Z Y,et al.Molecular mechanism of Epimedii Folium in treatment of osteoporosis based on network pharmacology[J].China J Chin Mater Med,2019,44(18):4048-4052.
  12. 12.
    TEO Y L,CHEONG W F,CAZENAVE-GASSIOT A,et al.Pharmacokinetics of prenylflavonoids following oral ingestion of standardized Epimedium extract in humans[J].Planta Med,2019,85(4):347-355.
  13. 13.
    LU Y R,CHEN Y B,CUl Y L,et al.Progress of pharmacological research on icariin[J].Chin J Exp Tradit Med Form,2018,24(17):209-220.
  14. 14.
    ZENG H T,GUO J,CHEN Y.Research progress on pharmacology effects and new drug delivery system of icaritin[J].Chin Tradit Herb Drug,2020,51(20):5372-5380.
  15. 15.
    HE L,JIANG J J,CHEN H,et al.A review on pharmacological effects and clinical application of Herba Epimedi[J].Clin J Chin Med,2020,51(20):5372-5380.
  16. 16.
    WEl J J,ZHANG J K ,Ll M,et al.A new flavonoid glycoside from Epimedium sagittatum[J].Acta Pharmaceut Sin,2023,58(1):180-185.
  17. 17.
    ZHOU X J,YAO X M,ZHOU Y Y.Research progress on pharmacological effects of Epimedium[J].Acta Chin Med Pharmacol,2022,50(11):112-115.
  18. 18.
    YANG J,ZHANG H F,CAO X Y,et al.Enzymatic water extraction of polysaccharides from Epimedium brevicornu and their antioxidant activity and protective effect against DNA damage[J].J Food Biochem,2017,41(1):e12298.
  19. 19.
    GUO Y S.Effect of Chinese traditional medicine polysaccharide asimmunopotentiators on PRRSV attenuated vaccine[D].Guangzhou:South China Agricultural University,2019.
  20. 20.
    ZOU Y,XIAO M,MENG Y H,et al.Effect and mechanism of action of Epimedii Folium polysaccharides[J].Chin J Exp Tradit Med Form,2024,30(10):20-28.
  21. 21.
    LI X Y,JIN L Y,XU X F,et al.Effect of Epimedium polysaccharides on antioxidant function in chicks[J].Chin J Veterinary Med,2019,55(10):56-59.
  22. 22.
    WANG L,HUANG J R,YU W G.Goat weed extract and the repair of radiation-induced immune system damage[J].J Yangtze Univ:Natural Sci Ed,2020,17(4):110-115.
  23. 23.
    TAN L,CHEN R Z,LU J,et al.The molecular characterization and immunomodulatory activities investigation of polysaccharides from epimedium[J].J Mol Sci,2017,33(3):190-195.
  24. 24.
    YANG Y J,LI C,CHEN F F,et al.Composition and immunomodulatory activity of neutral and acidic polysaccharides isolated from Epimedii Folium[J].China J Chin Mater Med,2022,47(16):4358-4364.
  25. 25.
    MATSUSHITA H,MIYASE T,UENO A,et al.Lignan andterpene glycosides from Epimedium sagittatum[J].Phytochemistry,1991,30(6):2025-2027.
  26. 26.
    KOGA S,SHOYAMA Y,NISHIOKA I.Studies on Epimedium species:Flavonol glycosides and isozymes[J].Biochem Syst Ecol,1991,19(4):315-318.
  27. 27.
    YANG R,LIU C Y,XU T,et al.Investigation of adsorption properties of five macroporous resins for total flavonoids in Epimedii Folium[J].Chin J Exp Tradit Med Form,2020,26(6):113-120.
  28. 28.
    GUO B L,WANG C L,CHEN J M,et al.Determination of 9 flavonoids in 5 species of Epimedium recorden in Chinese pharmacopoeia by HPLC[J].Acta Pharmaceut Sin,1996,31(4):292-295.
  29. 29.
    CUI X L,HUANG S Y.Study on flavones of Epimedium sagittatum[J].J Harbin Univ Commerce:Nat Sci Ed,2011,27(1):17-20.
  30. 30.
    HAN H,SHAN Q,ZHOU F J,et al.Chemical constituents in Epimedium sagittatum and their in vitro antitumor activities[J].Drugs Clin,2013,28(3):269-273.
  31. 31.
    WANG G J,TSAI T H,LIN L C.Prenylflavonol,acylated flavonol glycosides and related compounds from Epimedium sagittatum[J].Phytochemistry,2007,68(19):2455-2464.
  32. 32.
    CUI X L,DENG L L,HUANG S Y.Chemical constituents in Epimedium sagittatum and their in vitro antitumor activities[J].Chin J Exp Tradit Med Form,2010,16(13):101-103.
  33. 33.
    OSHIMA Y,OKAMOTO M,HIKINO H.Sagittatins A and B,flavonoid glycosides of Epimedium sagittatum Herbs1[J].Planta Med,1989,55(3):309-311.
  34. 34.
    YAN N,WEN D S,ZHAO Y R,et al.Epimedium sagittatum inhibits TLR4/MD-2 mediated NF-κB signaling pathway with anti-inflammatory activity[J].BMC Compl Altern Med,2018,18(1):303.
  35. 35.
    KURODA M,MIMAKI Y,SASHIDA Y,et al.Flavonol glycosides from Epimedium sagittatum and their neurite outgrowth activity on PC12h cells[J].Planta Med,2000,66(6):575-577.
  36. 36.
    WU Q L,ZHAO Y Q,LI Z L.Anstracts of original articles studies on the chemical constitutens of sagittate Epimedium[J].Chin Tradit Herb Drug,1995,26(9):451-452,503.
  37. 37.
    YI Y H,WANG Z L,ZHANG W X.A study of flavonoids in Epimedium sagittatum[J].Chin Pharmaceut J,1986,21(7):436.
  38. 38.
    CHEN C C,HUANG Y L,SUN C M,et al.New prenylflavones from the leaves of Epimedium saggitatum[J].J Nat Prod,1996,59(4):412-414.
  39. 39.
    LI D,IKEDA T,MATSUOKA N,et al.Cucurbitane glycosides from unripe fruits of Lo Han Kuo (Siraitiagrosvenori)[J].Chem Pharm Bull(Tokyo),2006,38:1425-1428.
  40. 40.
    SHEN Y X,TENG H L,YANG G Z,et al.A new chromone derivative from Berchemia lineata[J].Acta Pharm Sin,2010,45:1139-1143.
  41. 41.
    HAN B,SHEN T,JU J H,et al.Study on chemical components of Epimedium leptorrhizum[J].Chin Pharm J,2002,37:333-335.
  42. 42.
    CHEN Z,YING X,MENG S,et al.High-performance liquid chromatographic determination and pharmacokinetic study of apigenin-7-O-β-D-glucoside in rat plasma after intravenous administration[J].Arch Pharm Res,2011,34(5):741-746.
  43. 43.
    GAO M,LIU J J,SUN X G,et al.The HPLC determination of the content of magnoflorine in main species of Epimedii Herba[J].China J Chin Mater Med,2011,36(1):16-18.
  44. 44.
    LI L,WANG J R,WANG J,et al.Research progress on main chemical components and pharmacological effects of Yinyanghuo(Epimedium brevicornu Maxim) and predictive analysis on its quality marker[J].Chin Arch Tradit Chin Med,2023,41(11):143-151.
  45. 45.
    ZHAO H,ZHAO T,YANG J,et al.Epimedium protects against dyszoospermia in mice with Pex3k nockout by exerting antioxidant effects and regulating the expression level of P16[J].Cell Death Dis,2022,13(1):69.
  46. 46.
    GAO X Y,WANG W.The effect of icariin on the testes of cyclophosphamide induced spermatogenic disorders in rats[J].China Foreign Med Treat,2009,17:19-21.
  47. 47.
    TAN G H,WANG X,YAO C H,et al.Influence of icariine on Tripterygium glycosides model rat with pathological injury of testis[J].Guid J Tradit Chin Med Pharm,2009,15(7):8-10.
  48. 48.
    GE B,SHI Y,WANG L J.Effect of icariin on sperm quality and spermatid nuclear protein of rats[J].J Mod Med Health,2018,34(3):366-368.
  49. 49.
    FANG C Y,YE Y L,YE N J,et al.Mechanism of Epimedii Folium in treatment of oligoasthenotspermia based on network pharmacology and molecular docking[J].Chin J Exp Tradit Med Form,2022,28(19):194-203.
  50. 50.
    ZHANG S,WANG X,YI P F,et al.Effect of icariin on the development of ovarand uterus in sexually matured female rats[J].J Tradit Chin Veterinary Med,2007,26(2):15-18.
  51. 51.
    WU J S,ZHANG Y,WEN Y,et al.The effect of icariin on serum estradiol levels in ovariectomized mice[J].Guizhou Med J,2010,34(1):79-80.
  52. 52.
    ZHANG L,LI J L,GAO Y,et al.Research progress on pharmacological effects and mechanisms of icaritin[J].Chin Tradit Herba Drugs,2024,55(17):6069-6077.
  53. 53.
    LI K M,DAI M M,LI M X,et al.The mechanism of Yinyanghuo(Epimedium) in the treatment of polycystic ovary syndrome based on network pharmacology[J].Guid J Tradit Chin Med Pharm,2020,26(11):101-105.
  54. 54.
    DONG R X,ZHU X D,ZHANG Y,et al.Progress in the application of Epimedium and its main components in the treatment of premature ovarian failure[J].Shaanxi J Tradit Chin Med,2019,40(5):678-680.
  55. 55.
    WANG S Y,QIN M Z,LI F,et al.Effects of the crude and processed Epimedium sagittatum Maxim. on castrated mice[J].Chin Tradit Patent Med,2005(2):59-60.
  56. 56.
    HU H W,GAO Y,ZHOU Q G,et al.Comparative study on pharmacodynamics of Epimedium officinalis from different origins related to tonifying the kidney and strengthening Yang[J].Jiangxi J Tradit Chin Med,2022,53(8):59-62,68.
  57. 57.
    SHI M,PEI H,SUN L,et al.Optimization of the flavonoid extraction process from the stem and leaves of Epimedium brevicornum and its effects on cyclophosphamide-induced renal injury[J].Molecules,2023,29(1):207.
  58. 58.
    AN Y X,ZHANG X J,WANG Z,et al.Effect of icariin on rats with pulmonary fibrosis and its mechanism[J].Acta Univ Med Anhui,2020,55(12):1840-1844.
  59. 59.
    WANG X H,LI Z Y,LI X,et al.Effect of icariin on the expression of NAD(P)H:Quinine oxidoreductase 1, glutathione reductase and oxidative stress in asthmatic rats[J].Mod J Integr Tradit Chin West Med,2020,29(8):799-801,827.
  60. 60.
    XU C,HUANG X,TONG Y,et al.Icariin modulates the sirtuin/NF‑κB pathway and exerts anti‑aging effects in human lung fibroblasts[J].Mol Med Rep,2020,22(5):3833-3839.
  61. 61.
    WANG R,HOU F Y,ZENG M N,et al.Aqueous extract of Epimedium sagittatum mitigates pulmonary fibrosis in mice[J].China J Chin Mater Med,2023,48(20):5612-5622.
  62. 62.
    WANG C.Study on the effect of icaritin on elastase/lipopolysaccharide-induced lung inflammation[D].Guilin:Medical Colleges of Guilin,2023.
  63. 63.
    CONG Y J.Pulmonary biopharmaceutics study of Chuankezhi injection and icariinphospholipid complex[D].Beijing:Peking Union Medical College,2024.
  64. 64.
    ZHAO D,DONG H R,LIU X F,et al.Uptake and anti-inflammatory effect of icariin in alveolar epithelial A549 cells[J].Pharmacol Clin Chin Mater Med,2021,37(4):18-22.
  65. 65.
    LONG J,HUANG N Q,LUO Y.Research progress in the treatment of Alzheimer's disease with Yinyanghuo based on the theory of Shenzhugushengsui[J].Pharmacol Clin Chin Mater Med,2024,40(10):90-95.
  66. 66.
    SONG J,WANG C,LI Z Y,et al.Study on chemical constituents of total flavones for anti senile dementia from Epimedium Herb[J].Mod Chin Med,2009,11(8):23-26.
  67. 67.
    LIU X,WANG M Y,LU F J.Study on the mechanism of total flavonoids of Epimedium in preventing and treating Alzheimer's disease based on network pharmacology[J].Guangdong Chem Indust,2024,51(8):132-134,118.
  68. 68.
    CHEN Y,HAN S,HUANG X,et al.The Protective effect of icariin on mitochondrial transport and distribution in primary hippocampal neurons from 3× Tg-AD mice[J].Int J Mol Sci,2016,doi:.
  69. 69.
    SHENG C,XU P,ZHOU K,et al.Icariin attenuates synaptic and cognitive deficits in an Aβ1-42 induced rat model of Alzheimer's disease[J].Biomed Res Int,2017,2017:7464872.
  70. 70.
    NING B,ZHANG Q,WANG N,et al. Asarone regulates ER stress and autophagy via inhibition of the PERK/CHOP/Bcl-2/Beclin-1 pathway in 6-0HDA-induced Parkinsonian rat[J].Neurochem Res,2019,44(5):1159-1166.
  71. 71.
    ZHU T,ZHANG F,LI H,et al.Long-term icariin treatment ameliorates cognitive deficits via CD4+ T cell-mediated immuno-inflammatory responses in APP/PS1 mice[J].Clin Interv Aging,2019,14:817-826.
  72. 72.
    ZENG J,HUANG Y S,HUANG X H,et al.The anti-arrhythmia effect of Epimedium breuicornum Maxin(EBM)[J].J Gannan Med Univ,2002,22(1):12-14.
  73. 73.
    PEI Z F,XIA K,GAO Q L,et al.Protective effect of total flavonoids of Epimedium on endothelial cell injury induced by LPC[J].Central South Pharm,2009,7(6):410-412.
  74. 74.
    REN H.Pharmacological study on total flavonoids of Epimedium[J].J Med Inf,2011,24(1):299-301.
  75. 75.
    HE H,SHEN X J,FENG L.Protective effect of icariin on endothelial cell injury in atherosclerotic rabbits[J].Tradit Chin Med Res,2009,22(12):15-17.
  76. 76.
    GE J,LIN J,NING Q,et al.Evaluation of metabolism-effect/toxicity of Epimedium sagittatum based on zebrafish M-Act/Tox integration method[J].Chin Tradit Herb Drugs,2019,50(7):1614-1620.
  77. 77.
    HAN Z B.Effect of epimedium on expression levels of BMP-2 and BMP-4 genes in cartilage tissues of rabbit model of lumbarintervertebral disc degeneration[D].Bengbu:Bengbu Medical College,2019.
  78. 78.
    NIAN H,XU L L,MA M H,et al.Prevention of bone loss by aqueous extract of Epimedii sagittatum in an ovariectomized rat model of osteoporosis[J].J Integr Med,2006,4(6):628-633.
  79. 79.
    HU Y L,LI H,JI G M,et al.Chemical constituents with HDAC inhibitory effects from Epimedium sagittatum[J].Nat Product Res Develop,2021,33(10):1681-1690.
  80. 80.
    FENG K,XIE W,CHEN B L,et al.Effect of five species of Epimedium on growth of cartilage and proliferation of cartilage cell in vitro[J].China J Chin Mater Med,2006,31(24):2065-2067.
  81. 81.
    LIU Y M,ZHANG H Q,LIU Y P,et al.Active constituents and mechanism of Epimedii Folium against liver cancer:A review[J].Chin J Exp Tradit Med Form,2022,28(17):217-225.
  82. 82.
    ZANG Y L,LI J,ZENG R,et al.Screening effective sites of Momordicae Semen-Epimedii Folium and anti-lung cancer mechanism of its prescription[J].Chin J Exp Tradit Med Form,2024,30(8):17-25.
  83. 83.
    BI Y T,HUA D M,LIN J C,et al.Icariin inhibits proliferation of CLC5 Hepatoma cells via Akt/GSK3β/CDK pathway[J].Chin J Exp Tradit Med Form,2022,28(12):96-102.
  84. 84.
    YANG Y,WEI Y L,FANG F.Progress in the mechanism of icariin in the treatment of hematologic malignant tumors[J].Clin J Tradit Chin Med,2020,32(6):1182-1185.
  85. 85.
    GU Z M,ZHAN Y R,CHEN Y F,et al.Analysis of icariin in Epimedii Folium medicated serum and its anti-tumor effect study in vitro[J].J Guangdong Pharmaceut Univ,2020,36(4):499-503.
  86. 86.
    HUANG Z Q,CHEN X G,GUO B L,et al.Study on the mechanism oflcariside induced apoptosis in MDA-MB-231 cells[C]//Proceedings of the 10th CSNR National Symposium on Traditional Chinese Medicine and Natural Medicine Resources.The Natural Medicine Resources Professional Committee of the Chinese Society of Natural Resources,2012:636-640.
  87. 87.
    WANG R,ZENG M,ZHANG B,et al.Epimedium sagittatum Maxim ameliorates adriamycin-induced nephropathy by restraining inflammation and apoptosis via the PI3K/Akt signaling pathway[J].Immun Inflamm Dis,2023,11(6):e904.
  88. 88.
    BI Z,ZHANG W,YAN X.Anti-inflammatory and immunoregulatory effects of icariin and icaritin[J].Biomed Pharmacother,2022,151:113180.
  89. 89.
    XIE J P,JIANG X B.Antioxidant effects of extract from different parts of five natural plants:A comparative study[J].Food Sci,2010,31(21):173-175.
  90. 90.
    ZHANG Y Q,ZHOU S B,ZHANG Y L,et al.Effect of mixture of the Astragalus and Epimedium polysaccharide sulfate on immune index and blood antioxidation in mice[J].Chin J Prevent Veter Med,2020,42(7):706-711.
  91. 91.
    JIANG W,DING K,YUE R,et al.Therapeutic effects of icariin and icariside Ⅱ on diabetes mellitus and its complications[J].Crit Rev Food Sci Nutr,2023,2:1-26.
  92. 92.
    LU F,ZHANG K,LIU S M.Screening research on split fractions of Epimedium brevicornu Maxim based on anti-rheumatism effect[J].Clin J Tradit Chin Med,2019,31(1):105-110.
  93. 93.
    ZHANG X X,LIN T W,ZHANG J L,et al.Antidepressant effects of icariin in prenatally stressed offsprings[J].Chin Pharmacol Bull,2017,33(7):987-991.

قراءة النص الكامل

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website